A Novel Digital Educational Strategy Improves Treatment Adherence and Quality of Life in Patients with Multiple Myeloma
Author:
Funder
This work was supported by Janssen-Cilag S.A.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s13187-023-02374-w.pdf
Reference22 articles.
1. Siegel RL, Miller KD, Wagle NS et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48. https://doi.org/10.3322/caac.21763
2. Rajkumar SV (2022) Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 97(8):1086–1107. https://doi.org/10.1002/ajh.26590
3. Dimopoulos MA, Jakubowiak AJ, McCarthy PL et al (2020) Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J 10(2):17. https://doi.org/10.1038/s41408-020-0273-x
4. Xavier FD, Ferreira FSB, Abreu RM (2020) Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak. Oncotarget 11(47):4371. https://doi.org/10.18632/oncotarget.27819
5. Solano M, Daguindau E, Faure C et al (2021) Oral therapy adherence and satisfaction in patients with multiple myeloma. Ann Hematol 100(7):1803–1813. https://doi.org/10.1007/S00277-021-04543-7
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety;Interdisciplinary Cancer Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3